Testing effectiveness (Phase 2)UnknownNCT04961788
What this trial is testing
Anti-PD1 Antibody Toripalimab Combined With Gemox as First-line Therapy in Late-stage Intrahepatic Cholangiocarcinoma
Who this might be right for
Intrahepatic Cholangiocarcinoma
Shanghai Zhongshan Hospital 30